Inventor

DRESCHER KARLA

DE52 patents

⚠️ This page may combine multiple inventors who share the name “DRESCHER KARLA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DRESCHER KARLA

ABBVIE DEUTSCHLAND

Tricyclic quinoline and quinoxaline derivatives

Inhibitor compounds of phosphodiesterase type 10A

Inhibitor compounds of phosphodiesterase type 10A

Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators

Inhibitor compounds of phosphodiesterase type 10A

Inhibitor compounds of phosphodiesterase type 10A

Inhibitor compounds of phosphodiesterase type 10A

Inhibitor compounds of phosphodiesterase type 10A

Tricyclic quinoline and quinoxaline derivatives

Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors

Tricyclic quinoline and quinoxaline derivatives

Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor

Inhibitor compounds of phosphodiesterase type 10A

Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor

Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor

Hexahydrodiazepinoquinolines carrying a substituted alkyl radical

ABBOTT GMBH & CO KG

Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10A

Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

N-[(piperazinyl)hetaryl]arylsulfonamide compounds

Inhibitor compounds of phosphodiesterase type 10A

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Dibenzodiazepine derivatives, their preparation and use

Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

DRESCHER KARLA

Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

HAUPT ANDREAS

N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

TURNER SEAN COLM

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor

BRAJE WILFRIED

1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor

Tetrahydrobenzazepines and their use in he modulation of the dopamine D3 receptor

BASF AG

Substitute pyrimidine compounds and the use thereof

Triazole compounds and the use thereof

ABBOTT LAB

Substituted pyrimidine compounds and the use thereof

Triazole compounds and the use thereof

GENESTE HERVE

Inhibitor compounds of phosphodiesterase type 10A

ABBVIE INC

Treatment of central nervous system disorders

BITNER R SCOTT

Treatment of central nervous system disorders

SCHULTZ THOMAS

Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

UNGER LILIANE

Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor